Our mission is to profoundly improve people’s lives by delivering a new class of RNA therapeutics – AOCs. Our proprietary AOCs are designed to combine the specificity of monoclonal antibodies with the precision of oligonucleotide therapies to target the root cause of diseases previously untreatable with RNA therapeutics. Our advancing and expanding pipeline includes multiple skeletal muscle programs. We are also broadening the reach of AOCs beyond muscle tissues through both internal discovery efforts and key partnerships as the company continues to deliver on the RNA revolution.
Click on an RSS button(s) below and copy the URL into your RSS Reader to receive a feed of updated information from this site.
Not familiar with RSS? RSS is an XML-based (eXtensible Markup Language) format for content distribution that you view with an RSS Reader. There are a wide range of RSS Readers available - Click here for a list of some of the most popular.